A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects

• Autores principales: Liu C (Autor), Lu H (Autor), Yuan F (Autor), Chen WL (Autor), Xu HR (Autor), Li H (Autor), Hsu CP (Autor), Egbuna O (Autor), Wu J (Autor), Dias C (Autor), Abosaleem B (Autor), Rana J (Autor), Monsalvo ML (Autor), Li XN (Autor), Yu Z (Autor)
• Formato: Libro
• Publicado: Dove Medical Press, 2019-10-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Chao Liu,1 Hong Lu,2 Fei Yuan,1 Wei-Li Chen,1 Hong-Rong Xu,1 Hui Li,1 Cheng-Pang Hsu,3 Ogo Egbuna,3 Jihua Wu,2 Clapton Dias,3 Bassam Abosaleem,3 Jitesh Rana,3 Maria Laura Monsalvo,3 Xue-Ning Li,1 Zhigang Yu4 1Department of Clinical Pharmacology, Zhongshan Hospital, Fudan University, Shanghai, People...